Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer.

Oncotarget - 1 Dec 2015

Yao Lushuai, Ren Shancheng, Zhang Minjie, Du Fengxia, Zhu Yasheng, Yu Hui, Zhang Chenyu, Li Xiaohua, Yang Caiyun, Liu Huixian, Wang Dong, Meng Hao, Chang Shuang, Han Xiao, Sun Yinghao, Sun Yingli

Abstract excerpt

As a diagnostic biomarker, prostate special antigen (PSA) tests always generate false positive results and lead to unnecessary and/or repeat biopsies. Therefore, there is an urgent need for developing more sensitive, specific diagnostic biomarkers. We epigenotyped methylated sites in cancer tissues and adjacent normal tissues from 66 patients. In comparison with normal adjacent tissues, we observed that there...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Immunoprecipitation
Share to Chromosomes, Human, Y

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Real-Time Polymerase Chain Reaction

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 26485765
DOI: 10.18632/oncotarget.6141
PMCID: PMC4747356

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer.PMID 26485765Read ↗

Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate CancerSemantic proximity Read ↗

Aberrant DNA Methylation and Prostate CancerSemantic proximity Read ↗

Integrating Multi-Omics Data to Uncover Prostate Tissue DNA Methylation Biomarkers and Target Genes for Prostate Cancer Risk.Semantic proximity Read ↗

DNA methylation changes in prostate cancer: current developments and future clinical implementationSemantic proximity Read ↗

Identification of Methylation Biomarkers for Early Detection of Prostate CancerSemantic proximity Read ↗

Biomarker potential of ST 6 GALNAC 3 and ZNF 660 promoter hypermethylation in prostate cancer tissue and liquid biopsiesSemantic proximity Read ↗

DNA Methylation in Prostate Cancer: Clinical Implications and Potential ApplicationsSemantic proximity Read ↗

A three‐gene DNA methylation biomarker accurately classifies early stage prostate cancerSemantic proximity Read ↗

Prognostic DNA Methylation Markers for Prostate CancerSemantic proximity Read ↗

Epigenetic biomarkers in prostate cancer: Current and future uses.Semantic proximity Read ↗

Biomarkers in Prostate Cancer EpidemiologySemantic proximity Read ↗

Prediction of Prognosis in Patients with Prostate Cancer by DNA Methylation ClassificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.